Outpatient Off-Label Gabapentin Use for Psychiatric Indications Among U.S. Adults, 2011-2016.
Sign Up to like & getrecommendations! Published in 2021 at "Psychiatric services"
DOI: 10.1176/appi.ps.202000338
Abstract: OBJECTIVE Gabapentin is widely prescribed off label in medical practice, including psychiatry. The U.S. Food and Drug Administration (FDA) warned of risks associated with gabapentin combined with central nervous system depressant (CNS-D) drugs, which are… read more here.
Keywords: use; 2011 2016; use psychiatric; gabapentin use ... See more keywords